Marc van der Valk

Research output

Research output per year 2001 2015 2016 2017 2021 2022 2023 2023

• 182 Article
• 12 Comment/Letter to the editor
• 9 Review article
• 5 Editorial
• 6 More
  • 3 Letter
  • 1 Report
  • 1 Chapter
  • 1 Phd-Thesis - Research and graduation internal

Research output per year

Research output per year

Search results

• 2023

  CASCADE protocol: exploring current viral and host characteristics, measuring clinical and patient-reported outcomes, and understanding the lived experiences and needs of individuals with recently acquired HIV infection through a multicentre mixed-methods observational study in Europe and Canada

  For CASCADE Collaboration, 11 May 2023, In: BMJ Open. 13, 5, p. e070837 e070837.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access

• Effect of the introduction of screening for cancer precursor lesions on anal cancer incidence over time in people living with HIV: a nationwide cohort study

  ATHENA national observational HIV cohort, 1 Feb 2023, In: The Lancet HIV. 10, 2, p. e97-e106

  Research output: Contribution to journal › Article › Academic › peer-review
  1 Citation (Scopus)

• Erratum: Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV in the Netherlands: A nationwide prospective cohort study (PLoS Med (2022) 19:10 (e1003979) DOI: 10.1371/journal.pmed.1003979)

  Hensley, K. S., Jongkees, M. J., Geers, D., GeurtsvanKessel, C. H., Mueller, Y. M., Dalm, V. A. S. H., Papageorgiou, G., Steggink, H., Gorska, A., Bogers, S., den Hollander, J. G., Bierman, W. F. W., Gelinck, L. B. S., Schippers, E. F., Ammerlaan, H. S. M., van der Valk, M., van Vonderen, M. G. A., Delsing, C. E., Gisolf, E. H., Bruns, A. H. W., & 14 othersLauw, F. N., Berrevoets, M. A. H., Sigaloff, K. C. E., Soetekouw, R., Branger, J., de Mast, Q., Lammers, A. J. J., Lowe, S. H., de Vries, R. D., Katsikis, P. D., Rijnders, B. J. A., Brinkman, K., Roukens, A. H. E. & Rokx, C., 1 Jan 2023, In: PLoS medicine. 20, 1, p. e1004159 e1004159.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access
  1 Citation (Scopus)

• Evaluating interventions to reduce behaviour associated with HCV reinfection in men who have sex with men: study protocol for a non-blinded, phase 2, randomised trial

  ICECREAM study group, Dec 2023, In: Trials. 24, 1, p. 193 193.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access

• External validation of the PAGE-B score for HCC risk prediction in people living with HIV/HBV coinfection

  ANRS CO3 Aquitaine Cohort, the Swiss HIV Cohort Study, EuroSIDA & ATHENA Observational Cohort Study, May 2023, In: Journal of Hepatology. 78, 5, p. 947-957 11 p.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access

• Hepatitis delta infection among persons living with HIV in Europe

  for EuroSIDA and SHCS, Apr 2023, In: Liver international. 43, 4, p. 819-828 10 p.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  1 Citation (Scopus)

• Immunogenicity of an Additional mRNA-1273 SARS-CoV-2 Vaccination in People With HIV With Hyporesponse After Primary Vaccination

  Jongkees, M. J., Geers, D., Hensley, K. S., Huisman, W., GeurtsvanKessel, C. H., Bogers, S., Gommers, L., Papageorgiou, G., Jochems, S. P., den Hollander, J. G., Schippers, E. F., Ammerlaan, H. S. M., Bierman, W. F. W., van der Valk, M., Berrevoets, M. A. H., Soetekouw, R., Langebeek, N., Bruns, A. H. W., Leyten, E. M. S., Sigaloff, K. C. E., & 10 othersvan Vonderen, M. G. A., Delsing, C. E., Branger, J., Katsikis, P. D., Mueller, Y. M., de Vries, R. D., Rijnders, B. J. A., Brinkman, K., Rokx, C. & Roukens, A. H. E., 1 Mar 2023, In: The Journal of Infectious Diseases. 227, 5, p. 651-662 12 p.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  1 Citation (Scopus)

• Long-term evolution of comorbidities and their disease burden in individuals with and without HIV as they age: analysis of the prospective AGEhIV cohort study

  AGEhIV Cohort Study, 1 Mar 2023, In: The Lancet HIV. 10, 3, p. e164-e174

  Research output: Contribution to journal › Article › Academic › peer-review
  1 Citation (Scopus)

• Reasons for not commencing direct-acting antiviral treatment despite unrestricted access for individuals with HIV and hepatitis C virus: a multinational, prospective cohort study

  InCHEHC study group, 1 Apr 2023, In: The Lancet. Public health. 8, 4, p. e294-e304

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  1 Citation (Scopus)

• Recent abacavir use and incident cardiovascular disease in contemporary-treated people with HIV

  Jaschinski, N., Greenberg, L., Neesgaard, B., Miró, J. M., Grabmeier-Pfistershammer, K., Wandeler, G., Smith, C., de Wit, S., Wit, F., Pelchen-Matthews, A., Mussini, C., Castagna, A., Pradier, C., D'Arminio Monforte, A., Vehreschild, J. R., Sönnerborg, A., Anne, A. V., Carr, A., Bansi-Matharu, L., Lundgren, J., & 12 othersGarges, H., Rogatto, F., Zangerle, R., Günthard, H. F., Rasmussen, L. D., Nescoi, C., van der Valk, M., Menozzi, M., Muccini, C., Mocroft, A., Peters, L. & Ryom, L., 1 Mar 2023, In: AIDS (London, England). 37, 3, p. 467-475 9 p.

  Research output: Contribution to journal › Article › Academic › peer-review
  2 Citations (Scopus)

• Robust Vaccine-Induced as Well as Hybrid B- and T-Cell Immunity across SARS-CoV-2 Vaccine Platforms in People with HIV

  Verburgh, M. L., van Pul, L., Grobben, M., Boyd, A., Wit, F. W. N. M., van Nuenen, A. C., van Dort, K. A., Tejjani, K., van Rijswijk, J., Bakker, M., van der Hoek, L., Schim van der Loeff, M. F., van der Valk, M., van Gils, M. J., Kootstra, N. A. & Reiss, P., 11 May 2023, (E-pub ahead of print) In: Microbiology spectrum. p. e0115523

  Research output: Contribution to journal › Article › Academic › peer-review

• The role of HIV/hepatitis B virus/hepatitis C virus RNA+ triple infection in end-stage liver disease and all-cause mortality in Europe

  Mocroft, A., Geressu, A., Beguelin, C., Llibre, J. M., Lazarus, J. V., Tomazic, J., Smidt, J., Parczewski, M., Brännström, J., Sedlacek, D., Degen, O., van der Valk, M., Paduta, D., Flamholc, L., Schmid, P., Orkin, C., Nielsen, L. N., Hoffmann, C., Beniowski, M., Oprea, C., & 2 othersBegovac, J. & Peters, L., 1 Jan 2023, In: AIDS. 37, 1, p. 91-103 13 p.

  Research output: Contribution to journal › Article › Academic › peer-review

• Treatment as prevention effect of direct-acting antivirals on primary hepatitis C virus incidence: Findings from a multinational cohort between 2010 and 2019

  InCHEHC study group, Feb 2023, In: EClinicalMedicine. 56, 101810.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  4 Citations (Scopus)

• Unmasking a hepatitis C genotype 3a/1b dual infection in an individual treated with elbasvir/grazoprevir

  van der Pluijm, R. W., Smits, L. P., Rebers, S. P., Schinkel, J. & van der Valk, M., 1 Mar 2023, In: Journal of Hepatology. 78, 3, p. e95-e96

  Research output: Contribution to journal › Comment/Letter to the editor › Academic
• 2022

  A highly virulent variant of HIV-1 circulating in the Netherlands

  Netherlands ATHENA HIV Observational Cohort, BEEHIVE Collaboration & Netherlands ATHENA HIV Observational Cohort†, 4 Feb 2022, In: Science. 375, 6580, p. 540-545 6 p., A30.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  15 Citations (Scopus)

• Anti-C5a antibody vilobelimab treatment and the effect on biomarkers of inflammation and coagulation in patients with severe COVID-19: a substudy of the phase 2 PANAMO trial

  the Amsterdam UMC COVID-19 Biobank Investigators, 1 Dec 2022, In: Respiratory research. 23, 1, 6 p., 375.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access
  1 Citation (Scopus)

• Associations between integrase strand-transfer inhibitors and cardiovascular disease in people living with HIV: a multicentre prospective study from the RESPOND cohort consortium

  Neesgaard, B., Greenberg, L., Miró, J. M., Grabmeier-Pfistershammer, K., Wandeler, G., Smith, C., de Wit, S., Wit, F., Pelchen-Matthews, A., Mussini, C., Castagna, A., Pradier, C., d'Arminio Monforte, A., Vehreschild, J. R. J., Sönnerborg, A., Anne, A. V., Carr, A., Bansi-Matharu, L., Lundgren, J. D., Garges, H., & 11 othersRogatto, F., Zangerle, R., Günthard, H. F., Rasmussen, L. D., Necsoi, C., van der Valk, M., Menozzi, M., Muccini, C., Peters, L., Mocroft, A. & Ryom, L., 1 Jul 2022, In: The Lancet HIV. 9, 7, p. e474-e485

  Research output: Contribution to journal › Article › Academic › peer-review
  10 Citations (Scopus)

• Hepatitis C Elimination in the Netherlands (CELINE): How nationwide retrieval of lost to follow-up hepatitis C patients contributes to micro-elimination

  on behalf of CELINE Study Group, Jul 2022, In: European Journal of Internal Medicine. 101, p. 93-97 5 p.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  4 Citations (Scopus)

• Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV in the Netherlands: A nationwide prospective cohort study

  Hensley, K. S., Jongkees, M. J., Geers, D., GeurtsvanKessel, C. H., Mueller, Y. M., Dalm, V. A. S. H., Papageorgiou, G., Steggink, H., Gorska, A., Bogers, S., den Hollander, J. G., Bierman, W. F. W., Gelinck, L. B. S., Schippers, E. F., Ammerlaan, H. S. M., van der Valk, M., van Vonderen, M. G. A., Delsing, C. E., Gisolf, E. H., Bruns, A. H. W., & 14 othersLauw, F. N., Berrevoets, M. A. H., Sigaloff, K. C. E., Soetekouw, R., Branger, J., de Mast, Q., Lammers, A. J. J., Lowe, S. H., de Vries, R. D., Katsikis, P. D., Rijnders, B. J. A., Brinkman, K., Roukens, A. H. E. & Rokx, C., 1 Oct 2022, In: PLoS medicine. 19, 10, p. e1003979 e1003979.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  2 Citations (Scopus)

• Improving indicator-condition guided testing for HIV in the hospital setting (PROTEST 2·0): A multicenter, interrupted time-series analysis

  HIV Transmission Elimination Amsterdam (H-TEAM) Initiative, HIV Transmission Elimination AMsterdam (H-TEAM) Initiative, The H-TEAM members are, H-TEAM Project Management & H-TEAM additional collaborators, 1 Dec 2022, In: The Lancet Regional Health - Europe. 23, p. 100515 100515.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  2 Citations (Scopus)

• Incidence of hypertension in people with HIV who are treated with integrase inhibitors versus other antiretroviral regimens in the RESPOND cohort consortium

  The RESPOND study group, Sept 2022, In: HIV medicine. 23, 8, p. 895-910 16 p.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  3 Citations (Scopus)

• Indoleamine 2,3-dioxygenase (IDO)-1 and IDO-2 activity and severe course of COVID-19

  Amsterdam UMC Covid-19 Biobank & also on behalf of the Amsterdam UMC COVID-19 Biobank Study Group, 2022, In: Journal of pathology. 256, 3

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  8 Citations (Scopus)

• Integrase Strand Transfer Inhibitor Use and Cancer Incidence in a Large Cohort Setting

  RESPOND study group, Mar 2022, In: Open forum infectious diseases. 9, 3, p. ofac029 ofac029.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  1 Citation (Scopus)

• Intentional- but not Unintentional Medication Non-adherence was Related with Beliefs about Medicines Among a Multi-Ethnic Sample of People with HIV

  Castelan, A., Nellen, J. F., van der Valk, M. & Nieuwkerk, P. T., 2022, (E-pub ahead of print) In: AIDS and Behavior.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  1 Citation (Scopus)

• Internet-guided HCV-RNA testing: A promising tool to achieve hepatitis C micro-elimination among men who have sex with men: A promising tool to achieve hepatitis C micro-elimination among men who have sex with men

  Prinsenberg, T., Schinkel, J., Zantkuijl, P., Davidovich, U., Prins, M. & van der Valk, M., Aug 2022, In: Journal of viral hepatitis. 29, 8, p. 677-684 8 p.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  2 Citations (Scopus)

• Long-Term Virological Treatment Outcomes in Adolescents and Young Adults With Perinatally and Non-Perinatally Acquired Human Immunodeficiency Virus

  ATHENA national observational HIV cohort, 1 Nov 2022, In: Open forum infectious diseases. 9, 11, p. ofac561 ofac561.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  1 Citation (Scopus)

• Low hepatitis C virus-viremia prevalence yet continued barriers to direct-acting antiviral treatment in people living with HIV in the Netherlands

  ATHENA observational cohort, 1 May 2022, In: AIDS (London, England). 36, 6, p. 773-783 11 p.

  Research output: Contribution to journal › Article › Academic › peer-review
  4 Citations (Scopus)

• Low Risk of Failing Direct-Acting Antivirals in People With Human Immunodeficiency Virus/Hepatitis C Virus From Sub-Saharan Africa or Southeastern Asia: A European Cross-Sectional Study

  for EuroSIDA, the Swiss HIV Cohort Study, and the ATHENA Observational Cohort, 1 Oct 2022, In: Open forum infectious diseases. 9, 10, p. ofac508 ofac508.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access

• Moving towards zero new HIV infections: The importance of combination prevention

  van Sighem, A. & van der Valk, M., 1 Aug 2022, In: The Lancet Regional Health - Western Pacific. 25, 100558.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access

• Neurofilament light increases over time in severe COVID-19 and is associated with delirium

  Amsterdam UMC Covid-19 Biobank, 26 Jul 2022, In: Brain Communications. 4, 4, fcac195.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  2 Citations (Scopus)

• Observational cohort study of rilpivirine (RPV) utilization in Europe

  EuroSIDA Study Group, 1 Dec 2022, In: AIDS Research and Therapy. 19, 12 p., 38.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  1 Citation (Scopus)

• Older people with well-controlled HIV have similar antibody and higher T-cell responses after vaccination against SARS-CoV-2 compared to demographically and lifestyle-comparable people without HIV

  Verburgh, M., van Pul, L., Grobben, M., Boyd, A., Wit, F., van Nuenen, A., van Dort, K., Tejjani, K., van Rijswijk, J., Bakker, M., van der Hoek, L., van der Loeff, M. S., van der Valk, M., van Gils, M., Kootstra, N. & Reiss, P., 1 Oct 2022, In: Journal of the International AIDS Society. 25, 6, SI, p. 7-9 3 p.

  Research output: Contribution to journal › Article › Academic › peer-review

• One in 10 Virally Suppressed Persons With HIV in The Netherlands Experiences ≥10% Weight Gain After Switching to Tenofovir Alafenamide and/or Integrase Strand Transfer Inhibitor

  Verburgh, M. L., Wit, F. W. N. M., Boyd, A., Verboeket, S. O., Reiss, P. & van der Valk, M., 1 Jul 2022, In: Open forum infectious diseases. 9, 7, p. ofac291 ofac291.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  2 Citations (Scopus)

• Phylogenetic estimation of the viral fitness landscape of HIV-1 set-point viral load

  Zhao, L., Wymant, C., Blanquart, F., Golubchik, T., Gall, A., Bakker, M., Bezemer, D., Hall, M., Ong, S. H., Albert, J., Bannert, N., Fellay, J., Grabowski, M. K., Gunsenheimer-Bartmeyer, B., Günthard, H. F., Kivelä, P., Kouyos, R. D., Laeyendecker, O., Meyer, L., Porter, K., & 8 othersvan Sighem, A., van der Valk, M., Berkhout, B., Kellam, P., Cornelissen, M., Reiss, P., Fraser, C. & Ferretti, L., 2022, In: Virus evolution. 8, 1, veac022.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access

• Similar Risk of Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Similar Nucleocapsid Antibody Levels in People with Well-Controlled Human Immunodeficiency Virus (HIV) and a Comparable Cohort of People Without HIV

  Verburgh, M. L., Boyd, A., Wit, F. W. N. M., Schim van der Loeff, M. F., van der Valk, M., Bakker, M., Kootstra, N. A., van der Hoek, L. & Reiss, P., 1 Jun 2022, In: Journal of infectious diseases. 225, 11, p. 1937-1947 11 p.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  4 Citations (Scopus)

• Sustained virological response after treatment with direct antiviral agents in individuals with HIV and hepatitis C co-infection

  HepCAUSAL Collaboration, 1 Dec 2022, In: Journal of the International AIDS Society. 25, 12, p. e26048

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  1 Citation (Scopus)

• Usability, acceptability, and self-reported impact of an innovative hepatitis C risk reduction intervention for men have sex with men: A mixed methods study: A mixed methods study

  Prinsenberg, T., Illidge, J., Zantkuijl, P., Bedert, M., Prins, M., van der Valk, M. & Davidovich, U., 18 Feb 2022, In: PLOS ONE. 17, 2, 18 p., e0263654.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  1 Citation (Scopus)
• 2021

  Autoantibodies against type I interferons are associated with multi-organ failure in COVID-19 patients

  with the Amsterdam U.M.C. COVID-19 Biobank Investigators, 1 Jun 2021, In: Intensive care medicine. 47, 6, p. 704-706 3 p.

  Research output: Contribution to journal › Letter › Academic › peer-review

  Open Access
  60 Citations (Scopus)

• Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

  COVID Human Genetic Effort, Imagine COVID-Group, Danish CHGE, CONSTANCES cohort, Etablissement du Sang study group, St James's Hospital, SARS CoV2 Interest group, 3C-Dijon Study, COVID Clinicians, CoV-Contact Cohort, NIAID Immune Response to COVID Group, Cerba HealthCare, French COVID Cohort Study Group, HGID Lab, COVID-STORM Clinicians, NH-COVAIR Study Group, The Danish Blood Donor Study (DBDS), The Milieu Intérieur Consortium & Amsterdam UMC Covid-19 Biobank, 19 Aug 2021, In: Science immunology. 6, 62, 26 p., eabl4340.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  217 Citations (Scopus)

• Barriers to eliminating HIV transmission in England by 2030

  Nichols, B. E. & van der Valk, M., 1 Oct 2021, In: The Lancet. Public health. 6, 10, p. e699-e700

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access

• Changes in lung function among treated HIV-positive and HIV-negative individuals: analysis of the prospective AGEhIV cohort study

  AGEhIV Cohort Study, 1 Apr 2021, In: The Lancet Healthy Longevity. 2, 4, p. e202-e211

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  7 Citations (Scopus)

• Decreased Time to Viral Suppression After Implementation of Targeted Testing and Immediate Initiation of Treatment of Acute Human Immunodeficiency Virus Infection Among Men Who Have Sex With Men in Amsterdam

  HIV Transmission Elimination Amsterdam (H-TEAM) Initiative, 1 Jun 2021, In: Clinical Infectious Diseases. 72, 11, p. 1952-1960 9 p.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  10 Citations (Scopus)

• Direct-Acting Antiviral Treatment for Hepatitis C Genotypes Uncommon in High-Income Countries: A Dutch Nationwide Cohort Study

  Isfordink, C. J., van de Laar, T. J. W., Rebers, S. P. H., Wessels, E., Molenkamp, R., Knoester, M., Baak, B. C., van Nieuwkoop, C., van Hoek, B., Brakenhoff, S. M., Blokzijl, H., Arends, J. E., van der Valk, M. & Schinkel, J., 1 Feb 2021, In: Open forum infectious diseases. 8, 2, ofab006.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  4 Citations (Scopus)

• Erratum: Direct-Acting Antiviral Treatment for Hepatitis C Genotypes Uncommon in High-Income Countries: A Dutch Nationwide Cohort Study (Open Forum Infectious Diseases (2021) 8: 2 (ofab006) DOI: 10.1093/ofid/ofab006)

  Isfordink, C. J., van de Laar, T. J. W., Rebers, S. P. H., Wessels, E., Molenkamp, R., Knoester, M., Baak, B. C., van Nieuwkoop, C., van Hoek, B., Brakenhoff, S. M., Blokzijl, H., Arends, J. E., van der Valk, M. & Schinkel, J., 1 Aug 2021, In: Open forum infectious diseases. 8, 8, ofab197.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access

• Generally rare but occasionally severe weight gain after switching to an integrase inhibitor in virally suppressed AGE_hIV cohort participants

  AGEhIV Cohort Study Group, 1 May 2021, In: PLOS ONE. 16, 5 May, e0251205.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  6 Citations (Scopus)

• HCV micro-elimination in individuals with HIV in the Netherlands 4 years after universal access to direct-acting antivirals: a retrospective cohort study

  ATHENA observational cohort, Feb 2021, In: The Lancet HIV. 8, 2, p. e96-e105

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  27 Citations (Scopus)

• Head-to-head validation of six immunoassays for SARS-CoV-2 in hospitalized patients

  Amsterdam UMC Covid-19 Biobank, 1 Jun 2021, In: Journal of clinical virology. 139, 104821.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  7 Citations (Scopus)

• Hepatitis C Virus Transmission Among Men Who Have Sex With Men in Amsterdam: External Introductions May Complicate Microelimination Efforts

  Koopsen, J., Parker, E., Han, A. X., van de Laar, T., Russell, C., Hoornenborg, E., Prins, M., van der Valk, M. & Schinkel, J., 15 Jun 2021, In: Clinical Infectious Diseases. 72, 12, p. e1056-e1063

  Research output: Contribution to journal › Article › Academic › peer-review
  6 Citations (Scopus)

• Human Immunodeficiency Virus (HIV)-Negative Men Who Have Sex with Men Have Higher CD8+T-Cell Counts and Lower CD4+/CD8+T-Cell Ratios Compared with HIV-Negative Heterosexual Men

  The AGEhIV Study Group, 1 Oct 2021, In: Journal of infectious diseases. 224, 7, p. 1187-1197 11 p.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  4 Citations (Scopus)

• Incidence of HCV Reinfection among HIV-Positive MSM and Its Association with Sexual Risk Behavior: A Longitudinal Analysis

  Newsum, A. M., Matser, A., Schinkel, J., van der Valk, M., Brinkman, K., van Eeden, A., Lauw, F. N., Rijnders, B. J. A., van de Laar, T. J. W., van de Kerkhof, M., Smit, C., Boyd, A., Arends, J. E. & Prins, M., 1 Aug 2021, In: Clinical Infectious Diseases. 73, 3, p. 460-467 8 p.

  Research output: Contribution to journal › Article › Academic › peer-review
  22 Citations (Scopus)